Alkemy SpA
MIL:ALK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (37), the stock would be worth €10.4 (13% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 42.7 | €12 |
0%
|
| 3-Year Average | 37 | €10.4 |
-13%
|
| 5-Year Average | 17.8 | €4.99 |
-58%
|
| Industry Average | 15.9 | €4.46 |
-63%
|
| Country Average | 19.4 | €5.46 |
-55%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
|
Alkemy SpA
MIL:ALK
|
69.5m EUR | 42.7 | -4.4 | |
| UK |
|
Relx PLC
LSE:REL
|
48.2B GBP | 17.2 | 23.3 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 60 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
54.7B CAD | 35.5 | 26.9 | |
| IE |
|
Experian PLC
LSE:EXPN
|
24.3B GBP | 22.3 | 24.1 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
26B USD | 9.4 | 28.7 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.2B CHF | 9.9 | 24.4 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.6B USD | 13.9 | 29.5 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.4B USD | 12.8 | 12.7 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
17.7B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
14.9B EUR | 7.3 | 11.4 |
Market Distribution
| Min | 0.9 |
| 30th Percentile | 11.9 |
| Median | 19.4 |
| 70th Percentile | 28.4 |
| Max | 10 354.4 |
Other Multiples
Alkemy SpA
Glance View
Alkemy SpA provides marketing and information technology consulting services. The company is headquartered in Milan, Milano and currently employs 783 full-time employees. The company went IPO on 2017-12-05. The firm focuses on the development of digital transformation technologies, including design and implementation of solutions for the digitalization of business-to-business (B2B) and business-to-consumer (B2C) channels. Its offer comprises creation of digital and omnichannel strategies, data analytics and customer relationship management (CRM) tools, design of online stores, online content production, development of cross-channel campaigns, social media management, user experience (UX) design, execution of Websites and mobile applications, search engine optimization (SEO), retargeting, as well as integrated channel planning, among others.
